Theoretical Study of the Iron Complexes with Aminoguanidine: Investigating Secondary Antioxidant Activity
Open Access
- 15 August 2020
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 9 (8) , 756
Abstract
A thorough analysis of the thermodynamic stability of various complexes of aminoguanidine (AG) with Fe(III) at a physiological pH is presented. Moreover, the secondary antioxidant activity of AG is studied with respect to its kinetic role in the Fe(III) reduction to Fe(II) when reacting with the superoxide radical anion or ascorbate. Calculations are performed at the M05(SMD)/6-311+G(d,p) level of theory. Solvent effects (water) are taken into account in both geometry optimizations and frequency calculations employing the SMD solvation method. Even though the results of this study show that AG can form an extensive number of stable complexes with Fe(III), none of these can reduce the rate constant of the initial step of the Haber–Weiss cycle when the reducing agent is . However, when the reductant is the ascorbate anion, AG is capable of reducing the rate constant of this reaction significantly, to the point of inhibiting the production of •OH radicals. In fact, the most stable complex of Fe(III) with AG, having a of −37.9 kcal/mol, can reduce the rate constant of this reaction by 7.9 × 105 times. Thus, AG possesses secondary antioxidant activity relative to the Fe(III)/Fe(II) reduction with ascorbate, but not with . Similar results have also been found for AG relative to the Cu(II)/Cu(I) reduction, in agreement with experimental results.
Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (Discovery Grant)
- Thompson Rivers University (Undergraduate Research Experience Award Program (UREAP))
- Universitat de les Illes Balears (Visiting Professorship Award)
This publication has 49 references indexed in Scilit:
- Theoretical calculations of stability constants and pKa values of metal complexes in solution: application to pyridoxamine–copper(ii) complexes and their biological implications in AGE inhibitionPhysical Chemistry Chemical Physics, 2013
- DFT Studies on Schiff Base Formation of Vitamin B6 Analogues. Reaction between a Pyridoxamine-Analogue and Carbonyl CompoundsThe Journal of Physical Chemistry A, 2010
- Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface TensionsThe Journal of Physical Chemistry B, 2009
- Inhibition of Glycosylation Processes: the Reaction between Pyridoxamine and GlucoseChemistry & Biodiversity, 2005
- Maillard reaction products in tissue proteins: New products and new perspectivesAmino Acids, 2003
- Pimagedine: a novel therapy for diabetic nephropathyExpert Opinion on Investigational Drugs, 2002
- Chelating Activity of Advanced Glycation End-product InhibitorsJournal of Biological Chemistry, 2001
- Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptideBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Kinetics of the Competitive Degradation of Deoxyribose and Other Molecules by Hydroxyl Radicals Produced by the Fenton Reaction in the Presence of Ascorbic AcidFree Radical Research, 1995
- Ascorbate Autoxidation in the Presence of Iron and Copper ChelatesFree Radical Research Communications, 1986